Nakaya T - Search Results

1

Detection of Borna disease virus in a pregnant mare and her fetus.

Hagiwara K, Kamitani W, Takamura S, Taniyama H, Nakaya T, Tanaka H, Kirisawa R, Iwai H, Ikuta K. Hagiwara K, et al. Among authors: nakaya t. Vet Microbiol. 2000 Mar 15;72(3-4):207-16. doi: 10.1016/s0378-1135(99)00206-0. Vet Microbiol. 2000. PMID: 10727831

2

Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells from healthy horses in Japan.

Nakamura Y, Kishi M, Nakaya T, Asahi S, Tanaka H, Sentsui H, Ikeda K, Ikuta K. Nakamura Y, et al. Among authors: nakaya t. Vaccine. 1995 Aug;13(12):1076-9. doi: 10.1016/0264-410x(95)00050-b. Vaccine. 1995. PMID: 7491814

3

Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.

Nishino Y, Nakaya T, Fujinaga K, Kishi M, Azuma I, Ikuta K. Nishino Y, et al. Among authors: nakaya t. J Gen Virol. 1994 Sep;75 ( Pt 9):2241-51. doi: 10.1099/0022-1317-75-9-2241. J Gen Virol. 1994. PMID: 7521392

4

Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells.

Kishi M, Nakaya T, Nakamura Y, Zhong Q, Ikeda K, Senjo M, Kakinuma M, Kato S, Ikuta K. Kishi M, et al. Among authors: nakaya t. FEBS Lett. 1995 May 15;364(3):293-7. doi: 10.1016/0014-5793(95)00406-y. FEBS Lett. 1995. PMID: 7538936 Free article.

5

High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation.

Kameoka M, Kimura T, Okada Y, Nakaya T, Kishi M, Ikuta K. Kameoka M, et al. Among authors: nakaya t. Immunopharmacology. 1995 Jun;30(1):89-101. doi: 10.1016/0162-3109(95)00012-i. Immunopharmacology. 1995. PMID: 7591717

6

Extracellular Nef protein regulates productive HIV-1 infection from latency.

Fujinaga K, Zhong Q, Nakaya T, Kameoka M, Meguro T, Yamada K, Ikuta K. Fujinaga K, et al. Among authors: nakaya t. J Immunol. 1995 Dec 1;155(11):5289-98. J Immunol. 1995. PMID: 7594542

7

Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells.

Nakaya T, Fujinaga K, Kishi M, Oka S, Kurata T, Jones IM, Ikuta K. Nakaya T, et al. FEBS Lett. 1994 Oct 31;354(1):17-22. doi: 10.1016/0014-5793(94)01074-9. FEBS Lett. 1994. PMID: 7957894 Free article.

8

The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells.

Otake K, Fujii Y, Nakaya T, Nishino Y, Zhong Q, Fujinaga K, Kameoka M, Ohki K, Ikuta K. Otake K, et al. Among authors: nakaya t. J Immunol. 1994 Dec 15;153(12):5826-37. J Immunol. 1994. PMID: 7989778

9

[Molecular basis for HIV infection: implication for the therapy].

Nakaya T, Fujinaga K, Nishino Y, Kishi M, Ikuta K. Nakaya T, et al. Tanpakushitsu Kakusan Koso. 1994 Jun;39(8):1411-24. Tanpakushitsu Kakusan Koso. 1994. PMID: 8016374 Review. Japanese. No abstract available.

10

Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells.

Fujii Y, Nishino Y, Nakaya T, Tokunaga K, Ikuta K. Fujii Y, et al. Among authors: nakaya t. Vaccine. 1993 Sep;11(12):1240-6. doi: 10.1016/0264-410x(93)90049-4. Vaccine. 1993. PMID: 8256505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters